Compare Neurocrine Biosciences Inc (NBIX) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Zillow Group Inc Class C — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Zillow Group Inc Class C trades at $31.81 (market cap $7.54B). The key difference: Neurocrine Biosciences Inc is far larger — about 2.3× Zillow Group Inc Class C's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals.
| NBIX | Z | |
|---|---|---|
Market Cap | $17.40B | $7.54B |
Sector | Health | Media |
52-Week High | $180.55 | $90.35 |
52-Week Low | $123.10 | $29.41 |
Enterprise Value | $16.49B | $7.19B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
